node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
Cas6f | Q7A_1460 | Q7A_2609 | Q7A_1460 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | PFAM: Aminotransferase class I and II. | 0.520 |
Cas6f | Q7A_1898 | Q7A_2609 | Q7A_1898 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | PFAM: Aminotransferase class I and II. | 0.520 |
Cas6f | Q7A_2610 | Q7A_2609 | Q7A_2610 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | Hypothetical protein. | 0.904 |
Cas6f | Q7A_2611 | Q7A_2609 | Q7A_2611 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | Hypothetical protein. | 0.834 |
Cas6f | Q7A_2612 | Q7A_2609 | Q7A_2612 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | CRISPR-associated endonuclease Cas3-HD; PFAM: Type III restriction enzyme, res subunit; TIGRFAM: CRISPR-associated helicase Cas3; CRISPR-associated endonuclease Cas3-HD. | 0.932 |
Cas6f | Q7A_2614 | Q7A_2609 | Q7A_2614 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | Putative transcriptional regulator. | 0.418 |
Cas6f | Q7A_3065 | Q7A_2609 | Q7A_3065 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | PFAM: Aminotransferase class I and II. | 0.520 |
Cas6f | cas1 | Q7A_2609 | Q7A_2613 | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | CRISPR-associated protein Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.941 |
Q7A_1460 | Cas6f | Q7A_1460 | Q7A_2609 | PFAM: Aminotransferase class I and II. | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | 0.520 |
Q7A_1460 | cas1 | Q7A_1460 | Q7A_2613 | PFAM: Aminotransferase class I and II. | CRISPR-associated protein Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.522 |
Q7A_1898 | Cas6f | Q7A_1898 | Q7A_2609 | PFAM: Aminotransferase class I and II. | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | 0.520 |
Q7A_1898 | cas1 | Q7A_1898 | Q7A_2613 | PFAM: Aminotransferase class I and II. | CRISPR-associated protein Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.522 |
Q7A_2610 | Cas6f | Q7A_2610 | Q7A_2609 | Hypothetical protein. | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | 0.904 |
Q7A_2610 | Q7A_2611 | Q7A_2610 | Q7A_2611 | Hypothetical protein. | Hypothetical protein. | 0.857 |
Q7A_2610 | Q7A_2612 | Q7A_2610 | Q7A_2612 | Hypothetical protein. | CRISPR-associated endonuclease Cas3-HD; PFAM: Type III restriction enzyme, res subunit; TIGRFAM: CRISPR-associated helicase Cas3; CRISPR-associated endonuclease Cas3-HD. | 0.571 |
Q7A_2610 | cas1 | Q7A_2610 | Q7A_2613 | Hypothetical protein. | CRISPR-associated protein Cas1; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.436 |
Q7A_2611 | Cas6f | Q7A_2611 | Q7A_2609 | Hypothetical protein. | PFAM: CRISPR-associated protein (Cas_Csy4); TIGRFAM: CRISPR-associated protein Cas6/Csy4, subtype I-F/YPEST. | 0.834 |
Q7A_2611 | Q7A_2610 | Q7A_2611 | Q7A_2610 | Hypothetical protein. | Hypothetical protein. | 0.857 |
Q7A_2611 | Q7A_2612 | Q7A_2611 | Q7A_2612 | Hypothetical protein. | CRISPR-associated endonuclease Cas3-HD; PFAM: Type III restriction enzyme, res subunit; TIGRFAM: CRISPR-associated helicase Cas3; CRISPR-associated endonuclease Cas3-HD. | 0.765 |
Q7A_2611 | Q7A_2614 | Q7A_2611 | Q7A_2614 | Hypothetical protein. | Putative transcriptional regulator. | 0.533 |